Skip to main content
. 2023 Jan 9;95(2):e28430. doi: 10.1002/jmv.28430

Figure 1.

Figure 1

Summary of coronavirus disease 2019 (COVID‐19) rebound following nirmatrelvir/ritonavir treatment